Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-10-02
Summary
This study will be conducted to assess the baseline characteristics and evaluate the 90-day mortality of patients admitted with liver cirrhosis. Also, the study will be done to identify the risk factors of 90-day mortality.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Ahlam M Farghaly · [email protected]
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-07
- Primary Completion
- 2025-05-07
- Completion
- 2025-07-07
Countries
- Egypt
Study Locations
More Related Trials
-
Comparative Study of Novel Prognostic Scores in Patients With Liver Cirrhosis
NCT07238543 ·Status: NOT_YET_RECRUITING
-
Infections in Hospitalized Cirrhotic Patients
NCT03137719 ·Status: COMPLETED
-
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
NCT05170854 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Nutritional Status of Patients With Liver Cirrhosis
NCT03242798 ·Status: COMPLETED
-
Acute Liver Injury in Patients With Pneumonia
NCT06103981 ·Status: NOT_YET_RECRUITING
-
Prognosis of Patients With Acute-on-chronic Liver Failure
NCT05393453 ·Status: UNKNOWN
-
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis
NCT03438916 ·Status: COMPLETED
-
Acute-On-Chronic Liver Failure in Zagazig University Hospitals
NCT03184636 ·Status: COMPLETED
-
Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as a Prognostic Predictor Among Patients With Acute on Top of Chronic Liver Cell Failure
NCT06857682 ·Status: ACTIVE_NOT_RECRUITING
-
Haemostatic Imbalance in Patients With Chronic Liver Disease
NCT03589430 ·Status: UNKNOWN
-
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
NCT07132515 ·Status: RECRUITING ·Phase: PHASE4
-
Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.
NCT03241823 ·Status: UNKNOWN
-
Von Willebrand Factor Levels in Patients With Liver Cirrhosis and Portal Hypertension
NCT06694090 ·Status: NOT_YET_RECRUITING
-
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056 ·Status: RECRUITING
-
Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study
NCT06948565 ·Status: RECRUITING
-
Prospective Cohort Study of Complications and Outcomes in Cirrhosis
NCT06374511 ·Status: RECRUITING
-
Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic
NCT03580577 ·Status: UNKNOWN
-
Effect of Variceal Eradication on Portal Circulation
NCT04538209 ·Status: UNKNOWN
-
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment
NCT03443934 ·Status: COMPLETED
-
To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.
NCT02465619 ·Status: WITHDRAWN
-
Evaluation of Different Etiologies of Obscure Ascites
NCT03205748 ·Status: UNKNOWN
-
Changes in Lab and Ultrasonography After Endoscopic Varisceal Treatment
NCT03269786 ·Status: UNKNOWN
-
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
NCT04658407 ·Status: UNKNOWN
-
Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals
NCT03884062 ·Status: COMPLETED
-
Stem Cell Transplantation in Cirrhotic Patients
NCT02943889 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2